Forget a Cash ISA! I’d invest in these 2 FTSE 100 shares today to make a million

I think these two FTSE 100 (INDEXFTSE:UKX) shares could offer high returns due, in part, to their low valuations.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Opening a Cash ISA could lead to long-term disappointment. Even the best rates available are lower than inflation, which means the spending power of your capital may fall over the long run.

By contrast, the FTSE 100 offers a relatively high dividend yield of over 4%. The index could also deliver impressive levels of capital growth, with its track record showing it’s likely to overcome the near-term risks currently faced.

As such, now could be the right time to invest in these two FTSE 100 stocks. They could offer high returns that ultimately improve your prospects of making a million in the long run.

GSK

The prospects for pharmaceutical companies, such as GSK (LSE: GSK), could improve over the coming years. A number of factors, such as an ageing world population and increasing urbanisation, may contribute to increasing demand for the company’s products. This could lead to a potential tailwind for the business as it embarks on a more focused strategy that has seen it dispose of a number of major consumer healthcare brands.

In addition, GSK may become a more popular stock among investors due to its relatively low correlation with the wider economy. At a time when investors are fearful about events such as Brexit, US political risks, and a global trade war, healthcare companies may seem to be a resilient means of generating growth.

With a price-to-earnings (P/E) ratio of 14.5, the company appears to offer good value for money compared to its sector peers. Its dividend yield of 4.6% is roughly in line with the wider index, but could grow at a fast pace due to favourable operating conditions over the coming years.

Compass Group

The financial performance of support services company Compass Group (LSE: CPG) over recent years has been highly impressive, as well as consistent. It has recorded an annualised rise in net profit of over 10% in the last five years, delivering growth in every year during the period.

Its consistent performance could attract investors who are looking for increasingly dependable returns during a period where global economic risks are heightened. Compass Group is forecast to record a rise in net profit of 9% in the current year, which suggests that its overall strategy is working well.

The company continues to make bolt-on acquisitions that could enhance its financial outlook. Its financial position suggests that there’s scope for it to engage in further M&A activity, while its recent strong performance in the US could continue as it seeks to widen margins in many of its key markets.

From a long-term risk/reward perspective, Compass Group appears to have strong appeal. It could offer a mix between impressive growth and relatively resilient returns that increases your chances of generating a seven-figure portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Compass Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Stack of British pound coins falling on list of share prices
Investing Articles

2 penny stocks this Fool thinks could deliver phenomenal returns!

Penny stocks are a risky but exciting asset class to invest in, prone to wild volatility. Our writer thinks he's…

Read more »

Buffett at the BRK AGM
Investing Articles

I’ve just met Warren Buffett’s first rule of investing. Here are 3 ways I did it

Harvey Jones has surprised himself by living up to Warren Buffett's most important investment rule. But is his success down…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Down 51% in 2024, is this UK growth stock a buy for my Stocks and Shares ISA?

Ben McPoland considers Oxford Nanopore Technologies (LSE:ONT), a UK growth stock that has plunged over 80% since going public in…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

These 3 growth stocks still look dirt cheap despite the FTSE hitting all-time highs

Harvey Jones is hunting for growth stocks that have missed out on the recent FTSE 100 rally and still look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Here’s how much I’d need to invest in UK income stocks to retire on £25k a year

Harvey Jones is building his retirement plans on a portfolio of top UK dividend income stocks. There are some great…

Read more »

Investing Articles

If I’d invested £5,000 in BT shares three months ago here’s what I’d have today

Harvey Jones keeps returning to BT shares, wondering whether he finally has the pluck to buy them. The cheaper they…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’d aim for a million, by investing £150 a week

Our writer outlines how he’d aim for a million in the stock market through regular saving, disciplined investing, and careful…

Read more »

Investing Articles

Here’s how the NatWest dividend could earn me a £1,000 annual passive income!

The NatWest dividend yield is over 5%. So if our writer wanted to earn £1,000 in passive income each year,…

Read more »